Document is current
Any future updates will be listed below
-
Authors
Stoffer-Marx, Michaela A.
Klinger, Meike
Luschin, Simone
Meriaux-Kratochvila, Silvia
Zettel-Tomenendal, Monika
Nell-Duxneuner, Valerie
Zwerina, Jochen
Kjeken, Ingvild
Hackl, Marion
Öhlinger, Sylvia
Woolf, Anthony
Redlich, Kurt
Smolen, Josef S.
Stamm, Tanja A. https://orcid.org/0000-0003-3073-7284
-
Funding
Funding for this research was provided by:
European Commission (20081301EU)
Professional organisation for occupational therapists “Ergotherapie Austria” and the professional organisation for physiotherapists “Physio Austria”
Austrian Science Fund ([P21912-B09])
“Projektförderpreis“ of the “Österreichische Gesellschaft für Rheumatologie & Rehabilitation” (2012)
- License Information
-
More Information
Article History
Received: 2 July 2018
Accepted: 15 October 2018
First Online: 9 November 2018
Ethics approval and consent to participate
: Obtained from the Medical University of Vienna with the number 1083/2012. Patient consent was obtained orally and in written format from each participant.
: The present manuscript does not contain any individual person’s data, such as individual details, images or videos.
: MAS has received speaker fees from MSD; none of them relate to this work.MK has received speaker fees from AbbVie; none of them relate to this work.SL has received speaker fees from MSD; none of them relate to this work.SMK has no competing interests.MZT has no competing interests.VN has received speaker’s fees from Eli Lilly, Novartis and Pfizer. None of these relate to this work.JZ has received honoraria/speaker’s fees from AbbVie, Astra Zeneca, AstroPharma, BMS, Celgene, MSD, Pfizer and Roche; none of them relate to this work.IK has no competing interests.MH has no competing interests.SÖ has no competing interests.AW has no competing interests.KR has received honoraria from AbbVie, Amgen, BMS, Wyeth, Jansen, Roche, Schering-Plough and Sanofi-Aventis; none of them relate to this work.JSS has received honoraria from AbbVie, Amgen, BMS, Wyeth, Jansen, Roche, Schering-Plough and Sanofi-Aventis; none of them relate to this work.TAS has received speaker’s fees from AbbVie, Janssen, MSD and Roche; none of them relate to this work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
